Put companies on watchlist
Cicor Technologies Ltd
ISIN: CH0008702190
WKN: 913744
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Cicor Technologies Ltd · ISIN: CH0008702190 · EQS - adhoc news (65 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 2025215
08 November 2024 07:00AM

Cicor is expanding into Sweden and plans to further strengthen its market position in Germany


Cicor Technologies Ltd / Key word(s): Mergers & Acquisitions
Cicor is expanding into Sweden and plans to further strengthen its market position in Germany

08-Nov-2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Bronschhofen, November 8, 2024 – Cicor Group (SIX Swiss Exchange: CICN) has acquired the Swedish development company Nordic Engineering Partner AB and thus establishes a significant presence in the Nordics. Additionally, Cicor is in advanced negotiations to acquire another German EMS provider.

The acquisition of Nordic Engineering Partner (NEP) AB gives Cicor a presence in Sweden, one of Europe's leading markets for advanced electronics in the healthcare technology, industrial and aerospace & defence sectors. The four engineering offices in the Stockholm area offer customised development services and prototype production for complex electronic systems. NEP has an attractive customer base in Cicor's target markets which, together with Cicor's existing customers, provides a strong platform for further growth. Nordic Engineering Partner has 45 employees and generated sales of SEK 52 million with an attractive operating margin in the last financial year ended 30 June 2024.

The integration of NEP is another important step in the transformation of Cicor towards becoming the leading pan-European electronics design and manufacturing partner in its chosen markets by 2028. Following the acquisition of Evolution Medtech (Bucharest, Romania) earlier in 2024, the acquisition of NEP again doubles Cicor's product development capacity and significantly broadens the portfolio of capabilities. The shareholders and management of NEP view Cicor as the ideal owner to continue NEP's journey from a small engineering firm to one of Sweden's leading electronics design houses. They will stay part of the team to support further development in alignment with Cicor's growth strategy. As part of the Cicor Group, NEP will continue to operate all sites in Sweden unchanged and with the existing staff, maintaining a clear focus on growth in Sweden, Norway, and Finland.

The target company in Germany is a service provider for the development and manufacturing of electronic assemblies and systems. Its long-standing customers include medium-sized companies and leading corporations, mainly in the industrial electronics and medical technology sectors. With its state-of-the-art machinery, excellent infrastructure, and further expansion reserves, this acquisition is an ideal next step in Cicor's growth strategy in Germany, Europe's largest electronics market. In the last financial year, the company generated sales between EUR 20-30 million with an operating margin at the level of the Cicor Group. The transaction is expected to be signed in the coming weeks, subject to the usual regulatory and other closing conditions and is expected to be completed in early 2025. With this acquisition, Cicor intends to further expand its market position in Germany while maintaining its focus on the three target markets of medical technology, aerospace & defence, and industry.

These transactions are another step on Cicor's path to becoming the leading pan-European development and manufacturing partner for sophisticated electronics. Cicor is committed to maintaining the highest service quality while expanding capabilities, ensuring that our valued customers continue to receive the highest quality solutions and support as we continue to expand our presence in key markets.

Contact
Cicor Management AG
Gebenloostrasse 15
CH-9552 Bronschhofen


Media & Investor Relations
Phone +41 71 913 73 00
Email: media@cicor.com

The Cicor Group is a globally active provider of full-cycle electronic solutions from research and development to manufacturing and supply chain management. Cicor’s approximately 3,350 employees at 20 locations are serving leaders from the medical, industrial and aerospace & defence industries. Cicor creates value to its customers through the combination of customer-specific development solutions, high-tech components, as well as electronic device manufacturing. The shares of Cicor Technologies Ltd. are traded at the SIX Swiss Exchange (CICN). For further information, please visit the website www.cicor.com.



End of Inside Information
Language: English
Company: Cicor Technologies Ltd
c/o Cicor Management AG, Gebenloostraße 15
9552 Bronschhofen
Switzerland
Phone: +41719137300
Fax: +41719137301
E-mail: info@cicor.com
Internet: www.cicor.com
ISIN: CH0008702190
Valor: 870219
Listed: SIX Swiss Exchange
EQS News ID: 2025215

 
End of Announcement EQS News Service

2025215  08-Nov-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2025215&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Cicor Technologies Ltd
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.